Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

DLBDLB
Showing 8 of 31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in DOLBY LABORATORIES INC

CITADEL ADVISORS LLC holds 582,031 shares of DLB (DOLBY LABORATORIES INC), worth $30.6M as of 2026-Q2. The position was increased (+1543.5% shares). DLB represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$30.6M

Current Shares

582,031

Total Value Change

+$14.3M

Total Shares Change

+369,607

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
582,031
+1543.5%
$30.6M0.0%$52.28
46
2026-Q1
Decreased
35,415
-69.1%
$2.1M0.0%$59.34
0
2025-Q4
Increased
114,552
+23.5%
$7.4M0.0%$63.11
33
2025-Q3
Increased
92,763
+46.2%
$6.7M0.0%$70.73
37
2025-Q2
Decreased
63,460
-46.7%
$4.7M0.0%$72.25
0
2025-Q1
Decreased
119,007
-65.0%
$9.6M0.0%$77.80
0
2024-Q4
Increased
339,853
+60.0%
$26.5M0.0%$75.36
41
2024-Q3
Decreased
212,424
-30.6%
$16.3M0.0%$73.55
0

Other major holders of DLB: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used